Biomarkers such as IL4, PLXND1, GATA2, and NBEA regulate the progression of IPF through the Notch signaling pathway, which may provide valuable targets for the development of therapeutic strategies for IPF. The gene discussed is GATA2; the disease is idiopathic pulmonary fibrosis.